Presentation
Synthetic Data Summit 2023 | Session 5: Applications in Complex Healthcare Settings
Title: Generating Synthetic Data for the NHS
Presentation
Synthetic Data Summit 2023 | Session 4: Applications of Synthetic Data in the Life Sciences Industry II
Title: Applications of Privacy Enhancing Technology to Data Sharing at a Global ...
Presentation
Synthetic Data Summit 2023 | Session 3: Applications of Synthetic Data in the Life Sciences Industry I
Title: Applications of Synthetic Data in Supporting Data Products and Analytics for Real ...
Presentation
Synthetic Data Summit 2023 | Welcome / Opening remarks
Speaker: Khaled El Emam GM and SVP, Replica Analytics; Professor, University of Ottawa
Presentation
Synthetic Data Summit 2023 | Session 1: Regulating Privacy Risks from Synthetic Data
Title: Assessing the Privacy Risks of Synthetic Data and Other PETs
Presentation
Synthetic Data Summit 2023 | Session 6: New Applications
Title: Assessing Utility and Building Industry Trust for Imaging Data in Healthcare
Presentation
Synthetic Data Summit 2023 | Closing Remarks
Speaker: Dorothee Bartels Chief Digital Officer, Aetion
Blog
Research Spotlight: A Deep Dive into a Real-World Reproducibility Study
Both real-world data (RWD) and real-world evidence (RWE) studies continue to effectively ...
Blog
Partnering to enhance Japanese RWD at a global scale: A Q&A with JMDC
JMDC, a leading Japanese health big data firm, and Aetion® recently announced a ...
Blog
Research Spotlight: Navigating Treatment Effectiveness in Rare Oncology with External Control Cohorts
Real-world data (RWD) has proven to be a pivotal tool in understanding patient treatment ...
Publication
Evaluating the Utility and Privacy of Synthetic Breast Cancer Clinical Trial Data Sets
This paper published in the Journal of Clinical Oncology: Clinical Cancer Informatics ...
Blog
What I saw at DIA RWE 2023
I am just back from Baltimore, Maryland, where I had the joy of attending DIA’s ...
Blog
Advancing RWE in Oncology with Aetion’s CARE Initiative
In late 2022, Aetion announced the launch of the Aetion Coalition to Advance Real‐World ...
Blog
What I saw at ICPE 2023
I just had the pleasure and privilege of attending the 39th International Conference on ...
Blog
Leveraging the SURF screening tool to understand how to identify whether RWE of effectiveness may be acceptable for regulatory decision-making for a clinical development program
Ulka Campbell, Ph.D., is Aetion’s Head of Scientific Strategy. In this role, she uses her ...
Publication
Consolidated Reporting Guidelines for Prognostic and Diagnostic Machine Learning Modeling Studies: Development and Validation.
The reporting of machine learning (ML) prognostic and diagnostic modeling studies is ...
Presentation
Demystifying HIPAA: Techniques for De-identifying Complex Multi-modal Data
Patricia Thaine, Co-Founder & CEO, Private AI
Publication
A comparison of synthetic data generation and federated analysis for enabling international evaluations of cardiovascular health
Our recent article in Scientific Reports entitled, A comparison of synthetic data ...
Presentation
Reuse health data safely via tech-enabled re-identification risk management
Braley Crandall, VP Operations, Replica Analytics
Blog
The Inflation Reduction Act Puts Real-World Evidence Front and Center
The drug price negotiation provisions of the Inflation Reduction Act (IRA) will ...
Blog
Implementation of synthetic data generation in the enterprise
By Khaled El Emam | Published: April, 2023 The following article was published by ...
Presentation
Privacy Protective Sharing of Health Datasets using De-identification and Synthetic Data Generation
Blog
Aetion submits comments to FDA on recent draft guidance on considerations for externally controlled trials
Earlier this week, Aetion submitted a letter to FDA commenting on the Agency’s recent ...
Blog
Setting Real-World Standards at ISPOR 2023
Aetion joins other industry experts at ISPOR 2023 to discuss standard-setting and ...